3LASKUS T,RADKOWSKI M,WANG LF,et al. Search for hepatitis C virus extrahepatic replication site in patients with acquired immunodeficiency syndrome:specific detection of negative strand viral RNA in tissue [J]. Hepotology, 1998,28 : 1398.
4SIMO R,LECUBE A,GENESCA J,et al. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection[J]. Diabetes Care,2006,29.2462-2466.
5KONRAD T,ZEUZEM S,VICINI P,et al. Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha[J]. Eur J Clin Invest, 2000,30 : 111-121.
6LO IACONO O,VENEZIA G,PETrA S,et al. The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C[J]. Aliment Pharmacol Ther, 2007,25 : 113.
3Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW,Houghton M. Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
4Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-364.
5Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995;15:5-14.
6Mansell CJ, Locarnini SA. Epidemiology of hepatitis C in the East. Semin Liver Dis 1995;15:15-32.
7Mamiya N, Worman HJ. Hepatitis C virus core protein binds to a DEAD box RNA helicase. J Biol Chem 1997;274:15751-15756.
8National institutes of health consensus development panel.Hepatology 1997;26:1S-156S.
9Arao M, Murase K, Kusakabe A, Yoshioka K, Fukuzawa Y,Ishikawa T, Tagaya T, Yamanouchi K, Ichimiya H, Sameshima Y, Kakumu S. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol 2003;38:355-360.
10Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.Ann Intern Med 2000;133:592-599.
7KONRAO T,ZEAZEM S,VICINI P,et al.Evaluation of factors controcling glucose tolerence in pateints with HCV infection before and after 4 months therapy with interferon-α[J].Eur J Clin Invest,2000,30(2):111-121.
8LOLACONO O,VENEZIA G,PETTA S,et al.The impact of insulin resistance,serum adipocytokines and visceral obesity on statosis and fibrosis in patients with chronic hepatitos C[J].Aliment Parmacol Ther,2007,25(10):1181-1191.
